Catalyst Wire Dossier Catalyst Wire Dossier

THRIVE THerapeutic IntravasculaR Ultrasound Renal Denervation System (TIVUS)

· SoniVie Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for THRIVE THerapeutic IntravasculaR Ultrasound Renal Denervation System (TIVUS), covering 2026-04-02 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension [NA]

See pricing